Deoxycholic Acid API

Name	Deoxycholic acid
Chinese name	脱氧胆酸
Cas Number	83-44-3
Source	India
Qualifications	USDMF/-/-/-/-

Deoxycholic acid was developed by Kythera Biopharmaceuticals and was the world's first topical lipolytic drug approved by the U.S. Food and Drug Administration (FDA) in April 2015. Deoxycholic acid is a kind of free bile acid present in bile. It has strong surface activity and can destroy and dissolve cell membranes, reducing the dissolution of a small area of local subcutaneous fat. In clinical trials, deoxycholic acid can effectively eliminate submental fat and improve overall appearance compared to placebo. Deoxycholic acid, as a revolutionary product in the beauty industry, will provide a high-quality non-surgical treatment option for "double chin" people. Most patients can achieve satisfactory results after 2-4 injections. As a truly innovative product in the beauty industry, deoxycholic acid has considerable market potential. In addition, deoxycholic acid is also widely used in a variety of compound digestive enzymes, which can promote the secretion of bile and also has a good effect of promoting digestion. The industry predicts that the peak annual sales of deoxycholic acid will exceed 300 million US dollars. Exclusive supply of imported raw materials, support binding declaration.

Hot Tags: deoxycholic acid api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Dimethyl Fumarate API, Pazopanib Hydrochloride Pazopanib API, Adapalene API, Fondaparinux API, Aprepitant Aprepitant API, Troxagliptin Succinate API

• Previous: Vardenafil API
• Next: Lifitegrast API